肿瘤学:临床前,临床yaboapp体育官网试验和市场后
More than half a million people with cancer will die this year; our mission is to help you improve people's health and lives. From hundreds of preclinical药理学肿瘤模型和细胞系测定to running肿瘤学临床试验与市场后研究在数十个国家的数千名患者中,我们可以帮助您获得下一个突破性癌症药物精密药物治疗to those who desperately need it.
Achieve that cancer breakthrough, improving health & lives. . .
Preclinical Oncology
临床试验
在过去的五年中,考虑到了Covance的专业知识,见解和市场影响975 oncology studies(300例免疫肿瘤学)在83个国家的近19,000个地点,肿瘤学患者超过104,000名。
Data-driven and biomarker selection for patient recruitment
肿瘤学诊断
Featured screening & diagnostic tests:
- OmniSeq
- IntelliGEN® Myeloid
- PD-L1 Testing
yaboapp体育官网临床前免疫疗法
该行业已接近免疫肿瘤学from many angles, thus requiring identification, development and refinement of models capable of recapitulating optimal biological dynamics along with the associated and relevant endpoints.
精密药物和临床试验
Making gains in临床试验的精密药物需要新颖的方法来快速测试和靶向合适的个体。除了几十个后期免疫肿瘤临床试验, we have also supported more than 70% of allFDA-approved companion diagnostic products.

肿瘤学教育资源
我们期待着在很多人与您见面肿瘤学和免疫学事件this year.